XTL Biopharmaceuticals Ltd (XTLB) Stock Price, Quote, News & History

XTLBNASDAQ
$2.88
-0.10-3.36%
Last update: Aug 19, 9:29 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-1.02M
Investing Cash Flow (TTM)
522.00K
Financing Cash Flow (TTM)
208.00K
Free Cash Flow (TTM)
-1.02M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-295.00K

Valuation Metrics

Enterprise Value
$7.02M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-48.32%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.10

Company Debt

Total Debt
$269.00K
LT Debt
-
LT Debt Issuance (TTM)
$208.00K
LT Debt Repayment (TTM)
-
Total Cash
$76.00K
Debt to Equity
-
Issuance of Debt (TTM)
$208.00K
Repayment of Debt (TTM)
$0

Key Statistics

Open
$2.87
Close
-
Volume / Avg.
1.81K / 73.09K
Day Range
$2.87 - $2.96
52 Wk Range
2.01 - 41.12
Market Cap
$7.08M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
1.33%
Days to Cover
6.97

About

Sector
Health Care
Industry
Biotechnology
XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharma...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy XTL Biopharmaceuticals (XTLB) stock?

A

You can purchase shares of XTL Biopharmaceuticals (NASDAQ:XTLB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are XTL Biopharmaceuticals (XTLB) competitors?

Q

What is the forecast, or price target, for XTL Biopharmaceuticals (XTLB) stock?

A

There is no analysis for XTL Biopharmaceuticals to provide a consensus price target.

Q

What is the current price for XTL Biopharmaceuticals (XTLB)?

A

The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $2.88 last updated August 19, 2026 at 9:29 AM EDT.

Q

Does XTL Biopharmaceuticals (XTLB) pay a dividend?

A

There are no upcoming dividends for XTL Biopharmaceuticals.

Q

When is XTL Biopharmaceuticals (NASDAQ:XTLB) reporting earnings?

A

XTL Biopharmaceuticals does not have any upcoming earnings scheduled.

Q

Is XTL Biopharmaceuticals (XTLB) going to split?

A

There is no upcoming split for XTL Biopharmaceuticals.

Q

What sector and industry does XTL Biopharmaceuticals (XTLB) operate in?

A

XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.